Foamix Pharmaceuticals Ltd. (FOMX) Stock Price, Quote, News and Overview
NASDAQ:FOMX - Nasdaq -
FOMX Quote, Performance and Key Statistics
2.99
-0.25 (-7.72%)
The current stock price of FOMX is 2.99 null. In the past month the price decreased by -34.14%. In the past year, price decreased by -31.42%.
About FOMX
Company Profile
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
Company Info
Foamix Pharmaceuticals Ltd.
2 HOLZMAN ST. WEIZMANN SCIENCE PARK
REHOVOT L3 76704
CEO: David Domzalski
Phone: 972-8931-6233
Foamix Pharmaceuticals Ltd. / FOMX FAQ
What is the stock price of Foamix Pharmaceuticals Ltd. today?
The current stock price of FOMX is 2.99 null. The price decreased by -7.72% in the last trading session.
What is the ticker symbol for Foamix Pharmaceuticals Ltd. stock?
The exchange symbol of Foamix Pharmaceuticals Ltd. is FOMX and it is listed on the Nasdaq exchange.
On which exchange is FOMX stock listed?
FOMX stock is listed on the Nasdaq exchange.
What is Foamix Pharmaceuticals Ltd. worth?
Foamix Pharmaceuticals Ltd. (FOMX) has a market capitalization of 184.13M null. This makes FOMX a Micro Cap stock.
What are the support and resistance levels for Foamix Pharmaceuticals Ltd. (FOMX) stock?
Foamix Pharmaceuticals Ltd. (FOMX) has a support level at 2.93 and a resistance level at 4.55. Check the full technical report for a detailed analysis of FOMX support and resistance levels.
Should I buy Foamix Pharmaceuticals Ltd. (FOMX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FOMX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FOMX, evaluating the profitability, health, valuation and growth aspects
- Foamix Pharmaceuticals Ltd. (FOMX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Foamix Pharmaceuticals Ltd. (FOMX) Sales and EPS estimates to see what analysts future expectations are.
- Foamix Pharmaceuticals Ltd. (FOMX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Foamix Pharmaceuticals Ltd. (FOMX) Insider and Institutional Ownership to learn about the owners and their transactions.
- Foamix Pharmaceuticals Ltd. (FOMX) Stock Chart to make your own analysis
- Foamix Pharmaceuticals Ltd. (FOMX) Latest news and press-releases to stay up to date.
Does Foamix Pharmaceuticals Ltd. (FOMX) stock pay dividends?
FOMX does not pay a dividend.
What is the Price/Earnings (PE) ratio of Foamix Pharmaceuticals Ltd. (FOMX)?
Foamix Pharmaceuticals Ltd. (FOMX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.3).
FOMX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to FOMX. When comparing the yearly performance of all stocks, FOMX turns out to be only a medium performer in the overall market: it outperformed 56.46% of all stocks.
FOMX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to FOMX. FOMX may be in some trouble as it scores bad on both profitability and health.
FOMX Financial Highlights
Over the last trailing twelve months FOMX reported a non-GAAP Earnings per Share(EPS) of -1.3. The EPS increased by 34.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -21484.88% | ||
| ROA | -117.27% | ||
| ROE | N/A | ||
| Debt/Equity | 1.86 |
FOMX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to FOMX. The Buy consensus is the average rating of analysts ratings from 5 analysts.